Papers by Hai Lu · AgingResearch.News

Frontiers in Medicine2 Oct
Traditional Chinese medicine regulating Wnt/β-catenin and OPG/RANKL/RANK pathways in osteoporosis: a narrative review based on bone coupling and pathological subtype differences
ReviewOsteoporosis
Paper
Neuroepidemiology25 Aug
Burden of Stroke and Its Subtypes in Young Adults in China: A Systematic Analysis from 1990 to 2023 and Projections to 2050
Computational studyStroke
Paper
ADA Scientific Sessions 2026 Abstract6 Jun
Efficacy and Safety of a Novel Oral Small Molecule GLP-1 Receptor Agonist HDM1002 in Chinese Overweight and Obese Adults: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial
Trial in peopleInterventions
Paper
ADA Scientific Sessions 2026 Abstract6 Jun
Efficacy and Safety of a Novel Oral Small Molecule Glucagon-Like Peptide 1 Receptor Agonist (HDM1002) in Type 2 Diabetes Mellitus Patients Inadequately Controlled on Diet and Exercise or Metformin
Trial in peopleInterventions
Paper

ADA Scientific Sessions 2026 Abstract5 Jun
Efficacy and Safety of Dual GLP-1/GIP Receptor Agonist HDM1005 in Obese Participants without Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial
Trial in peopleInterventions
Paper
ADA Scientific Sessions 2025 Abstract13 Jun
Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of a Dual GLP-1/GIP Receptor Agonist (HDM1005)—A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Dose-Escalation Study
Trial in peopleInterventions
Paper